title: [The development of FSCLZLY--an ascites-ultrafiltration instrument].
abstract: It's known to all that the refractory ascites treatment has so far been a very difficult clinical problem. We have extracted much experience from the practical techniques used in the refractory ascites treatments of more than 1,000 cases, and have developed the ascites ultrafiltration & concentration therapeutic instrument--FSCLZLY-A. The clinical applications show that it is very effective. Its effective rate is about 72.08%. Therefore, it is a very useful and important medical device for refractory ascites, for the improvement of renal function, and for the prevention of the infection of abdominal cavity.
authors.affiliation: Institute of Liver Disease of the PLA, The General Hospital of Beijing Military Region.
authors.forename: Chao-ying
authors.initials: CY
authors.lastname: Liu
authors.forename: Da-rong
authors.initials: DR
authors.lastname: Hu
authors.forename: Xiao-jun
authors.initials: XJ
authors.lastname: Peng
authors.forename: Hui-ying
authors.initials: HY
authors.lastname: Tian
authors.forename: Li-juan
authors.initials: LJ
authors.lastname: Gong
authors.forename: Tian-bao
authors.initials: TB
authors.lastname: Chen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001201:Ascites / Q000628:therapy*; D004867:Equipment Design; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014462:Ultrafiltration / Q000295:instrumentation* / Q000379:methods